462510 · KOSDAQ · ₩462510 · 라메디텍
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−70.0% from the high
₩2,290Today: ₩2,450 – ₩2,720₩8,400
Returns
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
−6.7% on Oct 30, 2026.
We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.
Possible reasons, not certainties. Not financial advice.
Signals describe activity, not recommendations. Not financial advice.
Lameditech (라메디텍, KRX: 462510) is listed on KOSDAQ, in the Medical & precision devices sector. The company holds original technology for ultra-compact, high-power lasers and a compact laser platform used to develop new products. Its shares closed at ₩2,520 on Oct 30, 2026, down 6.67% on the day, giving it a market value of ₩22B.
The company holds original technology for ultra-compact, high-power lasers and a compact laser platform used to develop new products. It makes skin care and medical devices, including the Puracell series for aesthetic use, the Carebeam device for skin conditions such as atopy, vitiligo and psoriasis, and the Laybet device for pets, and it also produces ODM beauty devices sold through a global distribution partner. It also manufactures and sells laser blood-collection devices (Handylay series) for medical institutions and individuals, with its main operations based in Gasan-dong, Seoul.
Written by AI from the company's latest annual report.
Predicted impact: Low· Actual: −0.2% vs sector, volume 0.2× normal (5 trading days)
New skin booster laser technology push; no contract size or financial figures disclosed.
Titles in Korean until English translations are added.
Also known as: Lameditech / 라메디텍 / 462510 / KRX:462510
Source: KRX statistical information